View in EDS

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease.

Saved in:
Bibliographic Details
Title: Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease.
Authors: Tong, Koliarne1 (AUTHOR), Barker, Daniel2 (AUTHOR), France, Megan3 (AUTHOR), Burr, Lucy4 (AUTHOR), Greville, Hugh5 (AUTHOR), Visser, Simone6 (AUTHOR), Middleton, Peter7 (AUTHOR), Wainwright, Claire8 (AUTHOR), Dorahy, Douglas9 (AUTHOR), Wark, Peter1,9 (AUTHOR) Peter.wark@newcastle.edu.au
Source: Journal of Cystic Fibrosis. May2020, Vol. 19 Issue 3, p415-420. 6p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first